Trans-differentiation of myoblasts to adipoblasts: Triggering effects of fatty acids and thiazolidinediones

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 57, Issue 1, 1997, Pages 71-75

  Grimaldi, P A ^a   Teboul, L ^a   Inadera, H ^a   Gaillard, D ^a   Amri, E Z ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; CELL NUCLEUS RECEPTOR; FATTY ACID; LONG CHAIN FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; STEROID RECEPTOR;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOCHEMISTRY; IN VITRO STUDY; MITOCHONDRIAL MYOPATHY; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROADIPOCYTE; RAT; SATELLITE CELL;

ANIMALIA;

EID: 0030792539     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(97)90495-6     Document Type: Article

References (23)

1. Amri E. Z., Bertrand B., Ailhaud G., Grimaldi P. Regulation of adipose cell differentiation: I. Fatty acids are inducers of the aP2 gene expression. J Lipid Res 1991; 32: 1449-1456.
2. Amri E. Z., Ailhaud G., Grimaldi P. Regulation of adipose cell differentiation: H: Kinetics of induction of the aP2 gene by fatty acids and modulation by dexamethasone. J Lipid Res 1991; 32: 1457-1463.
3. Grimaldi P. A., Knobel S. M., Whitesell R. R., Abumrad N. A. Induction of the aP2 gene by nonmetabolized long-chain fatty acids. Proc Natl Acad Sci USA 1992; 89: 10930-10934.
4. Amri E. Z., Ailhaud G., Grimaldi P. A. Fatty acids as signal transducing molecules: involvement in the differentiation of preadipose to adipose cells. J Lipid Res 1994; 35: 930-937.
5. Ibrahimi A., Teboul L., Gaillard D., Amri E. Z., Ailhaud G., Young P., Cawthorne M. A., Grimaldi P. A. Evidence for a common mechanism of action for fatty acids and thiazolidinedione antidiabetic agents on gene expression in preadipose cells. Mol Pharmacol 1994; 46: 1070-1076.
6. Tontonoz P., Hu E., Graves R. A., Budavari A. I., Speigelman B. M. PPARγ2: Tissue-specific regulator of an adipocyte enhancer. Genes Dev 1994; 8: 1224-1234.
7. Amri E. Z., Bonino F., Ailhaud G., Abumrad N. A., Grimaldi P. A. Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. J Biol Chem 1995; 270: 2367-2371.
8. Chawla A. Lazar M. A. Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival. Proc Natl Acad Sci USA 1994; 91: 1786-1790.
9. Tontonoz P., Hu E., Spiegelman B. M. Stimulation of adipogenesis in flbroblasts by PPARγ2, a lipid-activated transcription factor. Cell 1994; 79: 1147-1156.
10. Forman B. M., Tontonoz P., Chen J., Brun R. P., Spiegelman B. M., Evans R. M. 15-deoxy-Δ12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ Cell 1995; 83: 803-812.
11. Kliewer S. A. Lenhard J. M., Willson T. M., Patel I., Morris D. C., Lehmann J. M. A prostaglandin J2 metabolite binds to PPARγ and promotes adipocyte differentiation. Cell 1995; 83: 813-819.
12. Tontonoz P., Hu E., Devine J., Beale E. G., Spiegelman B. M. PPAR-γ2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol Cell Biol 1995; 15: 351-357.
13. Schoonjans K. Watanabe M., Suzuki H., Mahfoudi A., Krey G., Wahli W., Grimaldi P., Staels B., Yamamoto T., Auwerx J. Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter. J Biol Chem 1995; 270: 19269-19276.
14. Grigoriadis A. E., Heersche N. M., Aubin J. E. Differentiation of muscle, fat, cartilage and bone from progenitor cells present in a bone-derived clonan cell population: effect of dexamethasone. J Cell Biol 1988; 106: 2139-2151.
15. Rosen D. M., Stempien S. A., Thompson A. Y., Seyedin S. M. Transforming growth factor-β modulates the expression of osteoblast and chondroblast phenotypes in vitro. J Cell Physiol 1988; 134: 337-346.
16. Katagiri T., Yamaguchi A., Ikeda T. et al. The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Commun 1990; 172: 295-299.
17. Katagiri T., Yamaguchi A., Komaki M. et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 1994; 127: 1755-1766.
18. Weintraub H., Tapscott S. J., Davis R. L., Thayer M. J., Adam M. A., Lassar A. B., Millar A. D. Activation of muscle-specific genes in pigment, nerve, fat, liver and fibroblast cell lines by forced expression of MyoD. Proc Natl Acad Sci USA 1989; 86: 5434-5438.
19. Rudnicki M. A., Schnegelsberg P. N. J., Stead R. H., Braun T., Arnold H. H., Jaenisch R MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 1993; 75: 1351-1359.
20. Umek R. M., Friedman A. D., McKnight S. L. CCAAT/enhancer binding protein: a component of a differentiation switch. Science 1991; 251: 288-292.
21. Wu Z., Xie Y., Bucher N. L. R., Farmer S. R. Conditional ectopic expression of C/EBPβ in NIH-3T3 cells incudes PPARγ and stimulates adipogenesis. Genes Dev 1995; 9: 2350-2363.
22. Yaffe D., Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 1977; 270: 725-727.
23. Teboul L.,Gaillard D., Staccini L. Inadera H., Amri E. Z., Grimaldi P. A. Thiazolidinediones and fatty acids convert myogenic cells into adipose-like cells. J Biol Chem 1995; 270: 28183-28187.